abstract |
The present invention relates to the use of compounds of the general formula (I) and to pharmaceutically acceptable acid addition salts thereof for the manufacture of medicaments for the treatment of diseases, related to the adenosine A2 receptor system like Alzheimer's disease, Parkinson disease, anxiety pain and other neurological disorders. |